| Choi, Steve |
NCT06267560: Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD |
|
|
| Recruiting | 3 | 400 | US | TQJ230, pelacarsen, Placebo | Novartis Pharmaceuticals | Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease | 03/27 | 03/27 | | |
SIS, NCT06597344: A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) |
|
|
| Recruiting | 3 | 90 | US | Gepotidacin | GlaxoSmithKline | Urinary Tract Infections | 03/25 | 03/25 | | |
NCT05026866: A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) |
|
|
| Active, not recruiting | 3 | 2196 | Japan, US | Donanemab, LY3002813, Placebo | Eli Lilly and Company | Alzheimer Disease | 11/27 | 11/27 | | |
NCT05138822: Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections |
|
|
| Completed | 1 | 140 | US | GSK3882347, Nitrofurantoin, Placebo | GlaxoSmithKline | Uncomplicated Urinary Tract Infections, Urinary Tract Infections | 12/24 | 12/24 | | |
NCT05107362: Clinical Performance of the Checkable Medical At-Home Strep A Test |
|
|
| Completed | N/A | 1347 | US | untrained lay user performs investigational diagnostic test | Checkable Medical Inc, Curebase Inc. | Streptococcus Pyogenes Infection, Pharyngitis, Respiratory Tract Infections | 07/23 | 07/23 | | |
NCT05817045: Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19 |
|
|
| Completed | N/A | 330 | US | RD-X19, Sham | EmitBio Inc. | COVID-19 | 06/24 | 06/24 | | |
| Not yet recruiting | N/A | 800 | US | Rapid point of care test to detect host immune response in ARI, Fingerstick test | Lumos Diagnostics, Biomedical Advanced Research and Development Authority | Acute Respiratory Infections (ARIs) | 05/25 | 06/25 | | |
NCT05672875: Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System |
|
|
| Terminated | N/A | 343 | US | Anthrax LF Dx System | SRI International, Department of Health and Human Services | Anthrax | 04/23 | 04/23 | | |
| Phillips, Caitlin |
| No trials found |
